Atlas Trials

Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists

Clinical trial NCT03405363 · COMPLETED

Trial details

NCT number
NCT03405363
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2018-01-31
Primary completion
2020-02-03
Enrollment
65406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.